Keratinocyte growth factor up-regulates interleukin-7 expression following intestinal ischemia/reperfusion in vitro and in vivo

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 6, 2012, Pages 569-580

  Cai, Yu Jiao ^a   Wang, Wen Sheng ^a   Liang, Hong Ying ^a   Sun, Li Hua ^a   Teitelbaum, Daniel H ^b   Yang, Hua ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Epithelial cells; Interleukin 7; Ischemia reperfusion; Keratinocyte growth factor; Mouse

Indexed keywords

BLOCKING ANTIBODY; FIBROBLAST GROWTH FACTOR RECEPTOR 2; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; COLON TUMOR; DISEASE MODEL; DRUG EFFECT; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; INTESTINE OBSTRUCTION; ISCHEMIA; MALE; METABOLISM; MOUSE; PATHOLOGY; REPERFUSION INJURY; TUMOR CELL LINE; UPREGULATION;

ANIMALS; ANTIBODIES, BLOCKING; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 7; HUMANS; INTERLEUKIN-7; INTESTINAL MUCOSA; INTESTINAL OBSTRUCTION; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECOMBINANT PROTEINS; REPERFUSION INJURY; UP-REGULATION;

EID: 84866043300     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischemia reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004; 49: 1359-77.
2. Grant D, Wall W, Mimeault R, Zhong R, Ghent C, Garcia B, Stiller C, Duff J. Successful small bowel/liver transplantation. Lancet 1990; 335: 181-4.
3. Grant D. Current results of intestinal transplantation. Lancet 1996; 347: 1801-3.
4. Soong CV, Blair PH, Halliday MI, McCaigue MD, Hood JM, Rowlands BJ, Barros D'SA. Bowel ischaemia and organ impairment in elective abdominal aortic aneurysm repair. Br J Surg 1994; 81: 965-8.
5. Gennaro M, Ascer E, Matano R, Jacobowitz IJ, Cunningham JN Jr, Uceda P. Acute mesenteric ischemia after cardiopulmonary bypass. Am J Surg 1993; 166: 231-6.
6. Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci 1994; 307: 284-92.
7. Vajdovich P. Free radicals and antioxidants in inflammatory processes and ischemia-reperfusion injury. Vet Clin North Am Small Anim Pract 2008; 38: 31-123.
8. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF related with properties of a paracrine effector of epithelial cell growth. Science 1989; 245: 752-5.
9. Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 1994; 266: 1253-5.
10. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 1989; 86: 802-6.
11. Revest JM, Suniara RK, Kerr K, Owen JJ, Dickson C. Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J Immunol 2001; 167: 1954- 61.
12. Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE, Aukerman SL, Devine PL, Whitehead RH, Pierce GF. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 1994; 94: 1764-77.
13. Yang H, Wildhaber B, Tazuke Y, Teitelbaum DH. 2002 Harry M. Vars research award: Keratinocyte growth factor stimulates the recovery of epithelial structure and function in a mouse model of total parenteral nutrition. JPEN J Parenter Enteral Nutr 2002; 26: 333-40; discussion 340-1.
14. Yang H, Wildhaber BE, Teitelbaum DH. 2003 Harry M. Vars Research Award. Keratinocyte growth factor improves epithelial function after massive small bowel resection. JPEN J Parenter Enteral Nutr 2003; 27: 198-206; discussion 206-7.
15. Finch PW, Pricolo V, Wu A, Finkelstein SD. Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology 1996; 110: 441-51.
16. Byrne FR, Farrell CL, Aranda R, Rex KL, Scully S, Brown HL, Flores SA, Gu LH, Danilenko DM, Lacey DL, Ziegler TR, Senaldi G. rHuKGF ameliorates symptoms in DSS and CD4tCD45rbHi T cell transfer mouse models of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2002; 282: G690-701.
17. Chen Y, Chou K, Fuchs E, Havran WL, Boismenu R. Protection of the intestinal mucosa by intraepithelial γδ T cells. Proc Natl Acad Sci USA 2002; 99: 14338-43.
18. Geiselhart LA, Humphries CA, Gregorio TA, Mou S, Subleski J, Komschlies KL. IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J Immunol 2001; 166: 3019-27.
19. Watanabe M, Ueno Y, Yajima T, Iwao Y, Tsuchiya M, Ishikawa H, Aiso S, Hibi T, Ishii H. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest 1995; 95: 2945-53.
20. Yang H, Sun X, Haxhija EQ, Teitelbaum DH. Intestinal epithelial cell-derived interleukin-7: A mechanism for the alteration of intraepithelial lymphocytes in a mouse model of total parenteral nutrition. Am J Physiol Gastrointest Liver Physiol 2007; 292:G84-91.
21. Yang H, Madison B, Gumucio DL, Teitelbaum DH. Specific overexpression of IL-7 in the intestinal mucosa: the role in intestinal intraepithelial lymphocyte development. Am J Physiol Gastrointest Liver Physiol 2008; 294: G1421-30.
22. Min D, Taylor PA, Panoskaltsis-Mortari A, Chung B, Danilenko DM, Farrell C, Lacey DL, Blazar BR, Weinberg KI. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bonemarrow transplantation. Blood 2002; 99: 4592-600.
23. Watanabe M, Yamazaki M, Okamoto R, Ohoka S, Araki A, Nakamura T, Kanai T. Therapeutic approaches to chronic intestinal inflammation by specific targeting of mucosal IL-7/IL-7R signal pathway. Curr Drug Targets Inflamm Allergy 2003; 2: 119-23.
24. Hayday A, Theodoridis E, Ramsburg E, Shires J. Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat Immunol 2001; 2: 997-1003.
25. Oshima S, Nakamura T, Namiki S, Okada E, Tsuchiya K, Okamoto R, Yamazaki M, Yokota T, Aida M, Yamaguchi Y, Kanai T, Handa H, Watanabe M. Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells. Mol Cell Biol 2004; 24: 6298-310.
26. Bhatia SK, Tygrett LT, Grabstein KH, Waldschmidt TJ. The effect of in vivo IL-7 deprivation on T cell maturation. J Exp Med 1995; 181: 1399-409.
27. Zlotnik A, Moore TA. Cytokine production and requirements during T-cell development. Curr Opin Immunol 1995; 7: 206-13.
28. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, Surh CD. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001; 98: 8732-7.
29. Yang H, Spencer AU, Teitelbaum DH. Interleukin- 7 administration alters intestinal intraepithelial lymphocyte phenotype and function in vivo. Cytokine 2005; 31: 419-28.
30. Yang H, Gumucio DL, Teitelbaum DH. Intestinal specific overexpression of interleukin-7 attenuates the alternation of intestinal intraepithelial lymphocytes after total parenteral nutrition administration. Ann Surg 2008; 248: 849-56.
31. Chailler P, Basque JR, Corriveau L, Ménard D. Functional characterization of the keratinocyte growth factor system in human fetal gastrointestinal tract. Pediatr Res 2000; 48: 504-10.
32. Hadari YR, Gotoh N, Kouhara H, Lax I, Schlessinger J. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc Natl Acad Sci USA 2001; 98: 8578-83.
33. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I, Schlessinger J. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 1997; 89: 693-702.
34. McKeehan WL, Wang F, Kan M. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol 1998; 59: 135-76.
35. Panoskaltsis-Mortari A, Taylor PA, Rubin JS, Uren A, Welniak LA, Murphy WJ, Farrell CL, Lacey DL, Blazar BR. Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury. Blood 2000; 96: 4350-6.
36. McKeehan WL, Wang F, Kan M. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol 1998; 59: 135-76.
37. Erickson M, Morkowski S, Lehar S, Gillard G, Beers C, Dooley J, Rubin JS, Rudensky A, Farr AG. Regulation of thymic epithelium by keratinocyte growth factor. Blood 2002; 100: 3269- 78.
38. Finch PW, Cunha GR, Rubin JS, Wong J, Ron D. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn 1995; 203: 223- 40.
39. Mason IJ, Fuller-Pace F, Smith R, Dickson C. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial- mesenchymal interactions. Mech Dev 1994; 45: 15-30.
40. Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, Lonai P. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 1993; 158: 475-86.
41. Yang H, Antony PA, Wildhaber BE, Teitelbaum DH. Intestinal intraepithelial lymphocyte gamma delta-T cell-derived keratinocyte growth factor modulates epithelial growth in the mouse. J Immunol 2004; 172: 4151-8.
42. Thiant S, Labalette M, Trauet J, Coiteux V, de Berranger E, Dessaint JP, Yakoub-Agha I. Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD. Bone Marrow Transplant 2011; 46: 1374-81.
43. McDuffie JE, Sablad M, Ma J, Snook S. Urinary parameters predictive of cisplatin-induced acute renal injury in dogs. Cytokine 2010; 52: 156-62.
44. Fukatsu K, Sakamoto S, Hara E, Ueno C, Maeshima Y, Matsumoto I, Mochizuki H, Hiraide H. Gut ischemia-reperfusion affects gut mucosal immunity: a possible mechanism for infectious complications after severe surgical insults. Crit Care Med 2006; 34: 182-7.